- £216.87bn
- £236.39bn
- $58.74bn
FTSE 100 subdued as energy, healthcare stocks limit broader gains
Live Markets: STOXX dragged down by weaker energy, healthcare
UK Stocks-Factors to watch on November 2 (updated)
Europe Research Roundup: Capgemini, Italgas, Saab
UK Stocks-Factors to watch on November 2
FTSE 100 logs first monthly gain in three; AstraZeneca jumps
Brief: AstraZeneca Says Looking At Developing Cancer Vaccines Internally For Now
Brief: AstraZeneca Says Restructuring Won't Lead To Net Reduction In Jobs
FTSE 100 set for monthly gains; AstraZeneca up after results
Corrected: BUZZ-AstraZeneca rises after Q3 results beat, launches $1.5 billion annual savings plan
AstraZeneca PLC reports results for the quarter ended September 30 - Earnings Summary
AstraZeneca rises after launching $1.5 billion annual savings plan
UK Stocks-Factors to watch on October 30 (updated)
AstraZeneca CEO strikes bullish tone on pipeline as stock rallies (updated)
AstraZeneca Q3 revenue rises 7% on Oncology unit strength
AstraZeneca kicks off savings drive to invest in pipeline after sales beat
3rd Quarter Results
UK Stocks- Factors to watch on October 30
Brief: Astrazeneca's Enhertu Approved In EU For HER2-Positive eBC